In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success.
phage activity
phage isolation
phage selection
phage therapy
phage virulence
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
07 07 2022
07 07 2022
Historique:
received:
31
03
2022
revised:
18
06
2022
accepted:
05
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Validated methods for phage selection, host range expansion, and lytic activity determination are indispensable for maximizing phage therapy outcomes. In this review, we describe some relevant methods, highlighting their advantages and disadvantages, and categorize them as preliminary or confirmatory methods where appropriate. Experimental conditions, such as the composition and consistency of culture media, have an impact on bacterial growth and, consequently, phage propagation and the selection of phage-resistant mutants. The phages require different experimental conditions to be tested to fully reveal their characteristics and phage therapy potential in view of their future use in therapy. Phage lytic activity or virulence should be considered as a result of the phage, its host, and intracellular/environmental factors, including the ability of a phage to recognize receptors on the bacterial cell surface. In vitro quantitative and qualitative measurements of phage characteristics, further validated by in vivo experiments, could be incorporated into one system or mathematical model/formula, which could predict a potential successful outcome of clinical applications.
Identifiants
pubmed: 35891470
pii: v14071490
doi: 10.3390/v14071490
pmc: PMC9323186
pii:
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Adv Colloid Interface Sci. 2017 Nov;249:100-133
pubmed: 28688779
Curr Opin Biotechnol. 2021 Apr;68:51-59
pubmed: 33126104
Bacteriophage. 2014 Dec 15;4(4):e964081
pubmed: 26713221
Viruses. 2018 Apr 03;10(4):
pubmed: 29614013
Evolution. 2008 Jan;62(1):1-11
pubmed: 18005153
Bacteriophage. 2017 Jan 4;6(4):e1270090
pubmed: 28090388
Methods Mol Biol. 2009;501:15-21
pubmed: 19066806
PLoS One. 2012;7(4):e34585
pubmed: 22514640
Pharmaceuticals (Basel). 2019 Mar 11;12(1):
pubmed: 30862020
mSphere. 2021 Jan 13;6(1):
pubmed: 33441407
Bio Protoc. 2021 Apr 20;11(8):e3997
pubmed: 34124298
J Immunol. 2018 May 1;200(9):3037-3044
pubmed: 29685950
Sci Rep. 2017 Apr 12;7:46151
pubmed: 28401893
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29555626
Front Microbiol. 2016 Oct 04;7:1590
pubmed: 27757110
Curr Opin Biotechnol. 2021 Apr;68:23-29
pubmed: 33113495
Methods Mol Biol. 2009;501:141-9
pubmed: 19066818
Front Microbiol. 2021 Mar 29;12:613529
pubmed: 33868187
Microbiol Mol Biol Rev. 2016 Jun 01;80(3):523-43
pubmed: 27250768
J Virol. 2013 Mar;87(6):3237-47
pubmed: 23302893
Lett Appl Microbiol. 2010 Oct;51(4):363-9
pubmed: 20796209
Front Microbiol. 2018 May 04;9:775
pubmed: 29780361
Antibiotics (Basel). 2022 Apr 26;11(5):
pubmed: 35625219
Viruses. 2018 Apr 05;10(4):
pubmed: 29621149
Appl Environ Microbiol. 2014 Feb;80(4):1469-76
pubmed: 24362424
Methods Mol Biol. 2009;501:69-76
pubmed: 19066811
J Appl Microbiol. 2011 Mar;110(3):631-40
pubmed: 21205097
J Evol Biol. 2016 Jan;29(1):188-98
pubmed: 26476097
MethodsX. 2018 Jan 31;5:159-172
pubmed: 30622914
Curr Drug Deliv. 2016;13(3):309-23
pubmed: 27090515
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5806-16
pubmed: 27431214
Trends Microbiol. 2019 Jan;27(1):51-63
pubmed: 30181062
Notes Rec R Soc Lond. 2020 Dec 20;74(4):579-597
pubmed: 33177748
J Appl Microbiol. 2009 Aug;107(2):646-56
pubmed: 19302306
PLoS One. 2015 May 07;10(5):e0127606
pubmed: 25950830
Adv Appl Microbiol. 2010;70:217-48
pubmed: 20359459
FEMS Microbiol Rev. 2004 May;28(2):127-81
pubmed: 15109783
Pharm Res. 2011 Apr;28(4):934-7
pubmed: 21063753
Methods Mol Biol. 2009;501:81-5
pubmed: 19066813
J Virol. 2015 Aug;89(15):7449-56
pubmed: 25972556
J Bacteriol. 1994 Feb;176(4):1069-76
pubmed: 8106318
Viruses. 2021 Jun 19;13(6):
pubmed: 34205417
J Basic Microbiol. 2014 Jun;54(6):531-41
pubmed: 23686910
Front Microbiol. 2016 Aug 12;7:1177
pubmed: 27570518
PeerJ. 2014 Sep 25;2:e590
pubmed: 25279269
Appl Environ Microbiol. 2006 Sep;72(9):6405-10
pubmed: 16957272
PLoS One. 2015 Aug 25;10(8):e0136007
pubmed: 26305566
Appl Environ Microbiol. 2015 Nov 20;82(3):808-15
pubmed: 26590277
Int J Food Microbiol. 2014 Feb 17;172:92-101
pubmed: 24361838
Pharmaceuticals (Basel). 2021 Nov 15;14(11):
pubmed: 34832944
Int J Microbiol. 2009;2009:259456
pubmed: 20016810
Clin Pharmacol Ther. 2000 Sep;68(3):225-30
pubmed: 11014403
Bacteriophage. 2011 Jan;1(1):46-49
pubmed: 21687534
Expert Rev Anti Infect Ther. 2011 Sep;9(9):775-85
pubmed: 21905786
Open Forum Infect Dis. 2018 Mar 23;5(4):ofy064
pubmed: 29687015
Nat Commun. 2022 Jan 18;13(1):302
pubmed: 35042848
FEMS Microbiol Lett. 2016 Apr;363(7):
pubmed: 26925588
Curr Pharm Biotechnol. 2010 Jan;11(1):69-86
pubmed: 20214609
PLoS One. 2009;4(3):e4944
pubmed: 19300511
Viruses. 2019 Mar 11;11(3):
pubmed: 30862096
Front Microbiol. 2017 Jun 15;8:981
pubmed: 28663740
Methods Mol Biol. 2018;1693:23-30
pubmed: 29119429
Antimicrob Agents Chemother. 2013 Dec;57(12):5961-8
pubmed: 24041900
Front Microbiol. 2021 Jan 21;11:609955
pubmed: 33552020
Virol J. 2013 Mar 06;10:76
pubmed: 23497209
PLoS One. 2014 Jun 25;9(6):e100426
pubmed: 24963920
Microbiologyopen. 2018 Apr;7(2):e00558
pubmed: 29195013
Microb Ecol. 2000 Aug;40(2):114-124
pubmed: 11029080
Pharm Res. 2015 Jul;32(7):2173-9
pubmed: 25585954
Methods Mol Biol. 2018;1693:75-84
pubmed: 29119433
PLoS One. 2011;6(10):e26648
pubmed: 22046321
BMC Microbiol. 2013 Jul 08;13:154
pubmed: 23834712
Methods Mol Biol. 2018;1693:99-110
pubmed: 29119435
Curr Pharm Biotechnol. 2010 Jan;11(1):2-14
pubmed: 20214604
PLoS One. 2011;6(9):e24418
pubmed: 21931710
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28807909
Bacteriophage. 2016 Jan 5;6(1):e1096995
pubmed: 27144083
Pharmaceuticals (Basel). 2021 Nov 13;14(11):
pubmed: 34832939
Evol Appl. 2013 Nov;6(7):1054-63
pubmed: 24187587
PLoS Pathog. 2009 Jan;5(1):e1000253
pubmed: 19119417
J Biol Chem. 2013 Feb 22;288(8):5581-90
pubmed: 23300085
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4547-53
pubmed: 20547834
Nat Med. 2019 May;25(5):730-733
pubmed: 31068712
J Infect Dis. 2001 Aug 1;184(3):337-44
pubmed: 11443560
Clin Microbiol Infect. 2014 Dec;20(12):O983-90
pubmed: 24920209
Viruses. 2018 Apr 12;10(4):
pubmed: 29649135
Appl Environ Microbiol. 2012 Aug;78(16):5646-52
pubmed: 22660719
Pol J Microbiol. 2010;59(3):145-55
pubmed: 21033576
Bacteriophage. 2016 Aug 5;6(3):e1219440
pubmed: 27738555
Front Microbiol. 2014 Nov 18;5:618
pubmed: 25477869
Science. 1998 Nov 20;282(5393):1432-5
pubmed: 9822369
Methods Mol Biol. 2009;501:161-74
pubmed: 19066821
Nat Rev Drug Discov. 2003 Jun;2(6):489-97
pubmed: 12776223